Funny thing with these type of FDA stocks.....first thing you look for is what kind of runs did other stocks with similar themed stories have run to. Most obvious one would be RPC which ran from .30 to almost $2.00 Who knows how high it could have gone if they didn't announce a big debt for equity swap priced way below market. Also RPC increased their shares O/S and float by almost 200% in one day.
Yes, things have gone bad with RPC now but the things that tripped them up were due to the massive debt they carried and the deperation this brought to embellish their relationship with Mayo. These negatives don't apply to BMOD. BMOD has next to no debt thanks to New Mexico funding our Phase II Trial.
So I think when results hit, this story starts to spread and the momo fire catches us here....I am looking for a similar run to what RPC did.
Market Data 
Markets 
AI
